Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Shares withheld for taxes Chief Operating Officer gave up 175 shares (to pay taxes)
  2. 4 Planned sale Director sold 26,756 shares at an average $152.51 ($4,080,663)
  3. 4 Open-market buy Director bought 250 shares at $150.69 ($37,673)
  4. 4 Grant or award CFO acquired 6,435 shares (grant or award)
  5. 4 Shares withheld for taxes Senior VP, R&D gave up 386 shares (to pay taxes)
  6. 4 Shares withheld for taxes Director gave up 10,142 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Operating Officer gave up 1,239 shares (to pay taxes)
  8. 4 Grant or award Chief Executive Officer acquired 14,480 shares (grant or award)
  9. 4 Shares withheld for taxes CFO gave up 316 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 343 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Operating Officer gave up 1,285 shares (to pay taxes)
  12. 4 Shares withheld for taxes Senior VP, R&D gave up 391 shares (to pay taxes)
  13. 4 Shares withheld for taxes Director gave up 2,825 shares (to pay taxes)
  14. 4 Shares withheld for taxes Senior VP, R&D gave up 275 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Operating Officer gave up 543 shares (to pay taxes)
  16. 4 Shares withheld for taxes Director gave up 2,380 shares (to pay taxes)
  17. 4 Option exercise Director acquired 11,808 shares (option exercise)
  18. 4 Open-market sale Director sold 24,246 shares at $139.67 ($3,386,439)
  19. 4 Shares withheld for taxes CFO gave up 367 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 861 shares (to pay taxes)

Page 4 of 34 · 669 filings